Log In
BCIQ
Print this Print this
 

GX101

  Manage Alerts
Collapse Summary General Information
Company Genovax s.r.l.
DescriptionTolerogenic vaccine that contains a fusion protein consisting of Fc region of immunoglobulin linked to a synthetic peptide made up of amino acid sequences from anti-DNA antibodies
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Peptide vaccine
Latest Stage of DevelopmentPreclinical
Standard IndicationLupus
Indication DetailsTreat systemic lupus erythematosus (SLE)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today